HOME NEWS EARNINGS RESULTS PICKS STRATEGY BLOG CONTACT SUBSCRIBE LOGIN SUBSCRIBE JOIN FREE
LOADING
Price Investing Group
← Back to Research Watchlist
MRNA
Moderna Inc
Healthcare Biotechnology · Massachusetts, USA · Reports in usd
Market Cap: $25.12B
Market Cap
$25.12B
Enterprise Val
$21.22B
P/E Ratio
-7.97
P/B Ratio
3.72
Trailing PEG (1Y)
1.06
As Of
Aug 13, 2026

Overview & Key Metrics

Reporting period: Jun 30, 2026 · Q2 2026
Book Value$6.76B
Gross Margin35.86%
Profit Margin35.86%
Return on Equity-39.20%
Return on Assets-26.86%
Current Ratio2.29
Debt/Equity0.18
LT Debt/Equity0.18
Revenue Per Share0.37

Income Statement

Jun 30, 2026
Revenue$145.0M
Cost of Revenue$93.0M
Gross Profit$52.0M
R&D$651.0M
SG&A$216.0M
Operating Expenses$867.0M
Operating Income-$815.0M
Interest Expense$0.00
Tax Expense$15.0M
Net Income-$782.0M
EPS (Basic)$-1.97
EPS (Diluted)$-1.97
EBIT-$767.0M
EBITDA-$704.0M
Consolidated Income-$782.0M
Non-Controlling Interests$0.00

Balance Sheet

Jun 30, 2026
Cash & Equivalents$1.72B
Accounts Receivable$17.0M
Inventory$280.0M
Current Assets$5.82B
LT Investments$1.77B
Property, Plant & Equipment$2.76B
Intangibles$0.00
Non-Current Assets$5.15B
Total Assets$10.96B
Accounts Payable$167.0M
Current Debt$0.00
Current Liabilities$2.53B
LT Debt$1.24B
Non-Current Liabilities$1.67B
Total Liabilities$4.20B
Total Debt$1.24B
Retained Earnings$5.10B
Shareholder Equity$6.76B
Shares Outstanding396,786,259

Cash Flow Statement

Jun 30, 2026
Operating Cash Flow-$526.0M
Investing Cash Flow$329.0M
Financing Cash Flow$14.0M
CapEx-$37.0M
Free Cash Flow-$563.0M
Depreciation & Amort.$63.0M
Stock-Based Comp$120.0M
Acquisitions / Disposals$0.00
Investment Activity$366.0M
Debt Issued/Repaid-$7.0M
Equity Issued/Repaid$23.0M
Dividends Paid$0.00
Net Change in Cash-$185.0M
Data cached · Meta cache · Daily cache · Statements cache · TTL 24h